Bausch Health Companies Inc. (NASDAQ:BHC) | WebDisclosure

Basculer en Français

8304	Companies
115195	Keywords
55510	Articles
62563	Press releases

Headlines Articles Press releases Bausch Health Companies Inc.

Home
Companies
Bausch Health Companies Inc.

BRIEF

published on 05/15/2024 at 14:05, 6 months 6 days ago

Bausch Health Announces 2024 Annual Meeting of Shareholder Results

Corporate Governance Bausch Health Shareholder Meeting Executive Compensation Omnibus Incentive Plan
BRIEF

published on 05/15/2024 at 14:05, 6 months 6 days ago

Bausch Health annonce les résultats de l’assemblée annuelle des actionnaires 2024

Assemblée Générale Gouvernance D'Entreprise Bausch Santé Rémunération Des Dirigeants Plan Incitatif Omnibus
PRESS RELEASE

published on 05/15/2024 at 14:00, 6 months 6 days ago

Bausch Health Announces 2024 Annual Meeting of Shareholder Results
Bausch Health Companies Inc. announces results of 2024 annual meeting of shareholders, including election of directors and approval of executive compensation

Shareholders Bausch Health Companies Inc. Annual Meeting Directors Executive Compensation
BRIEF

published on 05/14/2024 at 22:26, 6 months 7 days ago

Bausch Health annonce des mises à jour sur le litige Norwich XIFAXAN et une nouvelle soumission à la FDA

XIFAXAN Bausch Santé Contentieux Des Brevets Norwich Pharmaceutique Soumission À La FDA
BRIEF

published on 05/14/2024 at 22:26, 6 months 7 days ago

Bausch Health Announces Updates on Norwich XIFAXAN Litigation and New FDA Submission

XIFAXAN Bausch Health Patent Litigation FDA Submission Norwich Pharmaceuticals
PRESS RELEASE

published on 05/14/2024 at 22:21, 6 months 7 days ago

Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
Bausch Health and Salix Pharmaceuticals provide updates on litigation with Norwich Pharmaceuticals and potential generic version of XIFAXAN. Bausch Health to enforce intellectual property rights. Details on FDA approval process and patent infringement lawsuit

Salix Pharmaceuticals XIFAXAN Bausch Health Norwich Pharmaceuticals Intellectual Property Rights
BRIEF

published on 05/09/2024 at 14:05, 6 months 12 days ago

Salix Pharmaceuticals Appoints Bellamy Young as Spokesperson for Xifaxan Campaign

Salix Pharmaceuticals XIFAXAN FDA Approval Bellamy Young Overt Hepatic Encephalopathy
BRIEF

published on 05/09/2024 at 14:05, 6 months 12 days ago

Salix Pharmaceuticals nomme Bellamy Young porte-parole de la campagne Xifaxan

XIFAXAN Salix Pharmaceutique Approbation De La FDA Bellamy Jeune Encéphalopathie Hépatique Manifeste
PRESS RELEASE

published on 05/09/2024 at 14:00, 6 months 12 days ago

Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Bausch Health and Salix Pharmaceuticals announce Bellamy Young as Xifaxan brand ambassador to raise awareness on OHE recurrence risk reduction. Campaign aims to educate about complications of cirrhosis

Salix Pharmaceuticals XIFAXAN Bausch Health Bellamy Young OHE Recurrence
BRIEF

published on 05/02/2024 at 13:05, 6 months 19 days ago

Bausch Health Announces First Quarter 2024 Results

Financial Results Adjusted EBITDA Pharmaceutical Industry Revenue Growth Bausch Health

Accesswire

Published on 11/22/2024 at 09:00, 1 hour 33 minutes ago

Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 10 hours 33 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 12 hours 28 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 12 hours 43 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 14 hours 18 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 09:45, 48 minutes ago

The GSMA – China Unicom Open Gateway Global Use Case Innovation Challenge has begun!
Published on 11/22/2024 at 09:23, 1 hour 10 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding issuance of subordinated notes
Published on 11/22/2024 at 09:06, 1 hour 26 minutes ago

Original-Research: NFON AG (von NuWays AG): Buy
Published on 11/22/2024 at 09:05, 1 hour 27 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 11/22/2024 at 09:03, 1 hour 29 minutes ago

Amundi Physical Metals plc: UK Final Terms

Les Echos

Published on 11/21/2024 at 06:58, 1 day 3 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 3 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 3 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 14 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 15 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE